Flunisan (Fluoxetine) 20mg is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder and panic disorder.
Flunisan (Fluoxetine) 20mg is a selective serotonin reuptake inhibitors (SSRI) antidepressant. The way Flunisan works is still not fully understood. It is thought to positively affect communication between nerve cells in the central nervous system and/or restore chemical balance in the brain. Flunisan (Fluoxetine) 20mg is used to treat major depressive disorder, bulimia nervosa (an eating disorder) obsessive-compulsive disorder, and panic disorder.
Flunisan (Fluoxetine) 20mg is sometimes used together with another medication called olanzapine (Zyprexa). to treat depression caused by bipolar disorder (manic depression). This combination is also used to treat depression after at least 2 other medications have been tried without successful treatment of symptoms.
Flunisan (Fluoxetine) 20mg is used to treat depression, panic attacks, obsessive compulsive disorder, a certain eating disorder (bulimia), and a severe form of premenstrual syndrome (premenstrual dysphoric disorder).
Flunisan (Fluoxetine) 20mg may improve your mood, sleep, appetite, and energy level and may help restore your interest in daily living. It may decrease fear, anxiety, unwanted thoughts, and the number of panic attacks. It may also reduce the urge to perform repeated tasks (compulsions such as hand-washing, counting, and checking) that interfere with daily living. Flunisan (Fluoxetine) 20mg may lessen premenstrual symptoms such as irritability, increased appetite, and depression. It may decrease binging and purging behaviors in bulimia.
Use Flunisan delayed-release capsules as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Flunisan (Fluoxetine) 20mg with simultaneous application increases the effects of alprazolam, diazepam, ethanol and hypoglycemic drugs. With simultaneous application with Flunisan, the concentration of phenytoin, tricyclic antidepressants, maprotiline, trazodone is increased by a factor of 2 (it is necessary to reduce the dose of tricyclic antidepressants by 50% with simultaneous application).
Against the background of electroconvulsive therapy with simultaneous application with Flunisan (Fluoxetine) 20mg possible development prolonged epileptic seizures.
With simultaneous application with Flunisan, an increase in the concentration of lithium is possible, the risk of toxic effects of lithium increases, and frequent determination of the concentration of lithium in serum is recommended.
Tryptophan enhances the serotonergic properties of fluoxetine (increased agitation, motor anxiety, gastrointestinal disorders).
MAO inhibitors with simultaneous application with Flunisan (Fluoxetine) 20mg increase the risk of developing serotonin syndrome (hyperthermia, chills, increased sweating, myoclonus, hyperreflexia, tremor, diarrhea, movement coordination disorders, autonomic lability, agitation, nonsense and coma).
Drugs that exert a depressing effect on the central nervous system, while using with Flunisan (Fluoxetine) 20mg increase the risk of side effects and intensifying the inhibitory effect on the central nervous system.
With the simultaneous use of Flunisan with drugs that have a high degree of binding to proteins, especially with anticoagulants and digitoxin, it is possible to increase plasma concentrations of free (unbound) drugs and increase the risk of developing adverse effects.
Store Flunisan (Fluoxetine) 20mg at room temperature between 68-77 degrees F (20-25 degrees C) away from light and moisture. Do not store the drugs in the bathroom. Keep all drugs away from reach of children and pets.